By reducing vertical transmission of hepatitis B from mother to child to near zero levels and ensuring a safe supply of blood, tissues, and cells, many countries have shown that ambitious public health goals can be achieved. Now the challenge is to close the remaining gaps, particularly for hepatitis B vaccination and as well as harm reduction services targeted at people who inject drugs, helping Europe to eliminate hepatitis B and C by 2030 in line with the WHO target.